
HLA-DR/DP Antibody (HL-38) is a mouse monoclonal IgG2a antibody engineered to target the β-chain of HLA-DR and HLA-DP proteins, also known as Human Leukocyte Antigen DR and DP or MHC class II DR and DP. These proteins are essential components of the major histocompatibility complex (MHC) class II molecules, which play a critical role in the immune system by presenting processed antigenic peptides to CD4+ T helper cells, thereby initiating and regulating adaptive immune responses crucial for pathogen defense and immune surveillance. By binding to the β-chain of HLA-DR and HLA-DP, anti-HLA-DR/DP antibody (HL-38) enables precise detection and analysis of these proteins in various experimental applications, including western blotting (WB) under non-reducing conditions, immunoprecipitation (IP), and flow cytometry (FCM). Raised against the Raji cell line, a Burkitt′s lymphoma human cell line, HLA-DR/DP mouse monoclonal antibody (HL-38) recognizes human HLA-DR and HLA-DP across multiple species, including mouse and rat. The identification of HLA-DR and HLA-DP by HLA-DR/DP monoclonal antibody (HL-38) is vital for research into antigen presentation mechanisms, immune cell interactions, and the molecular underpinnings of immune-related diseases such as autoimmune disorders and cancers. Available in both conjugated and unconjugated forms, HLA-DR/DP (HL-38) antibody is an indispensable tool for immunologists and researchers aiming to elucidate the complexities of the immune system and advance immunological research and clinical applications.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
HLA-DR/DP Antibody (HL-38) | sc-51616 | 100 µg/ml | $322.00 | |||
HLA-DR/DP Antibody (HL-38) FITC | sc-51616 FITC | 100 tests in 2 ml | $336.00 |